TMC Life Sciences BhdXKLS:0101 62 EV-to-FCF is 21.23 as of Jul. 02, 2026. GuruFocus rates XKLS:0101 with a GF Score™ of 62/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 406 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks worse than 59.61% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, TMC Life Sciences Bhd's Enterprise Value is RM821.9 Mil.
TMC Life Sciences Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was RM38.7 Mil. Therefore, TMC Life Sciences Bhd's EV-to-FCF for today is 21.23.
The historical rank and industry rank for TMC Life Sciences Bhd's EV-to-FCF or its related term are showing as below:
XKLS:0101'
s EV-to-FCF Range Over the Past 10 Years
Min: -1809.68 Med: -11.23 Max: 3413.6
Current: 20.78
During the past 13 years, the highest EV-to-FCF of TMC Life Sciences Bhd was 3413.60. The lowest was -1809.68. And the median was -11.23.
XKLS:0101's EV-to-FCF is ranked worse than 59.61% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.57
vs XKLS:0101: 20.78
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
TMC Life Sciences Bhd (XKLS:0101) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
TMC Life Sciences Bhd's PE Ratio (TTM) for today is calculated as:
TMC Life Sciences Bhd's share price for today is RM0.45.
TMC Life Sciences Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's EV-to-FCF falls into.
TMC Life Sciences Bhd's current Enterprise Value is RM821.9 Mil.
TMC Life Sciences Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM38.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMC Life Sciences Bhd (XKLS:0101) has a EV-to-FCF of 21.23 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on TMC Life Sciences Bhd and its competitors. According to the industry distribution chart, TMC Life Sciences Bhd ranks #242 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 59.6%.
Is TMC Life Sciences Bhd's EV-to-FCF too high?
TMC Life Sciences Bhd's current EV-to-FCF is 21.23. The Healthcare Providers & Services industry median EV-to-FCF is 17.57. TMC Life Sciences Bhd's value of 21.23 is 20.8% above this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #242 out of 406 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, TMC Life Sciences Bhd has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #242 out of 406 companies for EV-to-FCF. This places TMC Life Sciences Bhd in the lower half of its industry. The industry median EV-to-FCF is 17.57. TMC Life Sciences Bhd's value of 21.23 is 20.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.57, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current EV-to-FCF of 21.23 is 20.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current EV-to-FCF is 21.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.45 — trading 27.4% below its estimated fair value. The current EV-to-FCF is 21.23 and 20.8% above the Healthcare Providers & Services industry median of 17.57. TMC Life Sciences Bhd's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current EV-to-FCF is 21.23 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?
Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued.
The current stock price of RM0.45 is trading 27.4% below its estimated GF Value™ of RM0.62.
GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0101:
EV-to-FCF: 21.23
GF Value™: RM0.62 vs. price of RM0.45 (27.4% below fair value)
Industry Position: 20.8% above the Healthcare Providers & Services median (#242 of 406)
No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
62GF Score
Get the complete analysis for XKLS:0101
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0101 has been successfully added to your 
